Is Low Cholesterol and Triglycerides a Sign of Pancreatic Cancer? - Gastroenterology and Hepatology

Share to:

Is there any basis for this statement?


Recently, I came across a physician citing a study from the United States indicating that a decrease in triglycerides and cholesterol could be a precursor to pancreatic cancer.
Is there any basis for this? According to the citation: In May of this year, American scholars proposed a new theory describing three phases of changes that occur in the body "before the onset of pancreatic cancer."
The first phase (30 to 18 months before pancreatic cancer diagnosis) involves the initial appearance of hyperglycemia, which can even occur up to three years prior to the diagnosis, although no noticeable changes in body tissues are observed at this time.

The second phase (18 to 6 months before diagnosis) sees a continued rise in blood glucose levels, while lipid levels (total cholesterol, low-density lipoprotein, and triglycerides) decrease, along with a reduction in body weight and subcutaneous fat.
At this stage, visceral fat and muscle mass remain unchanged, and high-density lipoprotein levels also do not vary.

The third phase (6 months to diagnosis) is characterized by the majority of individuals exhibiting hyperglycemia, alongside decreases in lipid levels, subcutaneous fat, visceral fat, and muscle mass, leading to noticeable weight loss.

ip, 30~39 year old female. Ask Date: 2020/05/31

Dr. Chen Shidian reply Gastroenterology and Hepatology


Further research is needed.

Reply Date: 2020/05/31

More Info


The assertion that low cholesterol and triglycerides may be indicators of pancreatic cancer is indeed a topic of ongoing research and debate within the medical community. Recent studies, including the one referenced, suggest that changes in metabolic parameters, such as elevated blood sugar levels and decreased lipid levels, can occur in the months or even years leading up to a pancreatic cancer diagnosis.

In the first stage, which occurs 30 to 18 months prior to diagnosis, elevated blood sugar levels are often the first sign. This can be attributed to the cancer's impact on insulin production and glucose metabolism. As the disease progresses into the second stage (18 to 6 months before diagnosis), it has been observed that while blood sugar continues to rise, levels of triglycerides and cholesterol may begin to decline. This paradoxical decrease in lipid levels can be attributed to the body's altered metabolism in response to the tumor's presence, which may lead to increased energy expenditure and changes in fat storage.

The third stage, occurring 6 months to the point of diagnosis, typically presents with significant weight loss, further decreases in triglycerides and cholesterol, and persistent high blood sugar levels. This stage often reflects the advanced nature of the disease, where the body is unable to maintain normal metabolic functions due to the cancer's systemic effects.

It is important to note that while these metabolic changes can be indicative of pancreatic cancer, they are not definitive markers. Many other conditions can lead to similar changes in blood sugar and lipid levels, including diabetes, liver disease, and other malignancies. Therefore, while low cholesterol and triglycerides may be associated with pancreatic cancer in some patients, they should not be used in isolation to diagnose the disease.

Moreover, the relationship between pancreatic cancer and lipid metabolism is complex. The pancreas plays a crucial role in fat digestion and metabolism, and pancreatic cancer can disrupt these processes, leading to alterations in lipid profiles. However, the exact mechanisms by which pancreatic cancer influences lipid metabolism are still being studied.

In clinical practice, the presence of low cholesterol and triglycerides, particularly in conjunction with other symptoms such as unexplained weight loss, jaundice, or new-onset diabetes, should prompt further investigation. This may include imaging studies, such as CT scans or MRIs, and possibly a biopsy to confirm or rule out pancreatic cancer.

In conclusion, while there is emerging evidence suggesting that low cholesterol and triglycerides may be associated with pancreatic cancer, more research is needed to establish a clear causal relationship. It is essential for healthcare providers to consider the full clinical picture, including patient history, symptoms, and other diagnostic findings, when evaluating the risk of pancreatic cancer. Regular monitoring and a comprehensive approach to patient care are crucial in managing potential pancreatic disorders.

Similar Q&A

Early Signs of Pancreatic Cancer: Blood Sugar and Weight Loss

Doctor, I would like to ask if elevated blood sugar levels or weight loss are common issues before a diagnosis of pancreatic cancer, or if these symptoms typically appear only in the later stages. Thank you.


Dr. Chen Sirong reply Oncology
Xiao Wei / 30 years old / Male 1. I would like to ask if elevated blood sugar levels or weight loss are common issues before a diagnosis of pancreatic cancer. A: Not necessarily. Some individuals may be asymptomatic and discover the diagnosis during routine check-ups, while oth...

[Read More] Early Signs of Pancreatic Cancer: Blood Sugar and Weight Loss


Managing Low Pancreatic Function and Triglycerides: Dietary Considerations

Hello, I have a cyst on my pancreas. Recently, during a check-up, my doctor found that my triglyceride level is only 33. The doctor prescribed me pancrelipase enteric-coated microgranules and ursodeoxycholic acid. I would like to know if adding an extra 15ml of flaxseed oil daily...


Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello! The presence of pancreatic cysts does not necessarily correlate with pancreatic insufficiency or low triglyceride levels. Whether consuming 15cc of oil alone is beneficial or harmful should be advised based on clinical conditions. It is recommended for individuals with gal...

[Read More] Managing Low Pancreatic Function and Triglycerides: Dietary Considerations


Symptoms of High Triglycerides and Effective Improvement Strategies

Elevated triglyceride levels can lead to various symptoms and health issues. Common symptoms may include: 1. Abdominal pain 2. Nausea 3. Fatigue 4. Pancreatitis (in severe cases) To improve high triglyceride levels, consider the following lifestyle changes: 1. Adopt a healthy ...


Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello, 1. Elevated triglycerides are a type of hyperlipidemia, which can lead to atherosclerosis and cardiovascular diseases. Triglyceride levels greater than 1000 mg/dL can trigger acute pancreatitis. 2. Treatment options: a. Lifestyle modifications - including dietary c...

[Read More] Symptoms of High Triglycerides and Effective Improvement Strategies


Understanding Elevated Cancer Antigen Levels and High Triglycerides: Key Considerations

Hello, doctor. 1. The company's health check showed that the embryonic cancer antigen (nuclear medicine) level is 3.5 ng/ml, which exceeds the standard by 0.1 ng/ml. What precautions should I take? 2. The triglyceride level was tested at 272 mg/dl, which is high. Are ther...


Dr. Hong Shouhong reply Family Medicine
Carcinoembryonic antigen (CEA) is a glycoprotein primarily used for monitoring after tumor resection. Elevated CEA levels may be associated with various cancers, such as colorectal, pancreatic, and breast cancers, but it is not specific. An elevated CEA level does not necessarily...

[Read More] Understanding Elevated Cancer Antigen Levels and High Triglycerides: Key Considerations


Related FAQ

Pancreatic Cancer

(Gastroenterology and Hepatology)

Pancreatic Tumor

(Gastroenterology and Hepatology)

Pancreas

(Gastroenterology and Hepatology)

Cancer

(Gastroenterology and Hepatology)

Pancreatitis

(Gastroenterology and Hepatology)

Pancreatic Cancer

(Oncology)

Cholecystectomy

(Gastroenterology and Hepatology)

Lower Abdomen

(Gastroenterology and Hepatology)

Obesity

(Gastroenterology and Hepatology)

Fecal Occult Blood

(Gastroenterology and Hepatology)